이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

식품 소비 및 대사의 객관적인 측정에 대한 예측 불가능성에 대한 인식의 영향 평가

예측 불가능성에 대한 인식이 식품 소비 및 대사의 객관적 측정에 미치는 영향 평가: 자연사 연구

Background:

Many people in the United States are overweight or obese. This natural history study will look into how life events during childhood can impact eating behaviors and weight gain as adults.

Objective:

To explore how childhood experiences affect adult eating behaviors.

Eligibility:

Healthy people aged 18 to 60 years.

Design:

Participants will have 3 clinic visits.

They will be screened with blood tests. They will answer questions about their alcohol and tobacco use.

At the next visit, participants will undergo these activities:

Parts of their body (such as waist, neck, and thighs) will be measured with a tape.

They will have an imaging scan to find out how much body fat they have.

They will start wearing a device like a wristwatch that measures their physical activity. They will wear this device for up to 10 days.

They will wear a device on their upper arm or belly that measures blood glucose (sugar) levels. Participants will wear this for 7-10 days.

They will answer questions about their education, childhood, and routines.

They will receive a kit to collect a stool sample at home.

At the last visit, participants will have these tests:

Participants will relax and breathe normally while wearing a clear, plastic canopy that fits over their entire head.

Blood samples will be taken before and after participants drink a sugary drink.

Participants will be offered a large selection of foods for lunch. They will eat as much as they want. Then they will answer questions about how they feel about food and themselves.

연구 개요

상태

아직 모집하지 않음

상세 설명

Study Description:

The unpredictability schema - "a pervasive belief that other people cannot be trusted and future outcomes cannot be predicted or controlled" - has been hypothesized to (1) be shaped by parental/household dynamics and (2) impact appetitive and consumptive behaviors. However, studies on appetitive behaviors were mostly based on self-report and to our knowledge, no studies have examined objective measurements of energy intake or expenditure in association with unpredictability. Therefore, the current study seeks to examine whether the unpredictability schema as measured by a composite score of unpredictability assessments is associated with ad libitum food consumption and eating in the absence of hunger, measured objectively. Furthermore, we will examine the associations between the unpredictability schema and physical activity, resting metabolic rate/respiratory quotient, and glucose trajectories during an oral glucose tolerant test and continuous glucose monitoring in a cohort of healthy participants.

Objectives:

Primary Objective:

  • To determine whether an association exists between unpredictability schema measures (schema/beliefs and childhood experiences as measured by derived from the Child Unpredictability Index, Scale of Unpredictability Beliefs, Unpredictability Schema Scale, and Confusion, Hubbub, and Order Scale and, individually, by scale totals and subscales) and ad libitum food intake.
  • To determine whether an association exists between the unpredictability schema and experience scores and eating in the absence of hunger (as determined by the snack food taste test).

Secondary Objectives:

  • To determine whether an association exists between the unpredictability schema and experience scores and self-reported appetitive eating traits and behavior (as measured by the Eating in the Absence of Hunger Scale, Body Awareness Questionnaire, Reward-Based Eating Drive Scale, U.S. Adult food Security Survey Module, and the Three-Factor Eating Questionnaire).
  • To determine whether an association exists between measures of the unpredictability schema and experience scores and physical activity.
  • To determine whether an association exists between measures of the unpredictability schema and experience scores and resting metabolic rate and RQ.
  • To determine whether an association exists between measures of the unpredictability schema and experience scores and glucose values (CGM and OGTT).
  • To determine whether an association exists between measures of the unpredictability schema and experience scores and telomere length.
  • To determine whether an association exists between measures of the unpredictability schema and experience scores and with gut microbiota composition.
  • To determine whether an association exists between measures of the unpredictability schema and experience scores with countylevel food swamp statistics (i.e., Retail Food Environment Index).

Tertiary Objectives:

  • To determine the associations between measures of early childhood experiences (as measured by an overall composite measure derived by the maternal care/warmth subscale of the Parental Bonding Instrument and physical and emotional neglect subscales from the Childhood Trauma Questionnaire and, individually, by scale totals and subscales) and outcomes outlined in the primary and secondary objectives.
  • To determine whether an association exists between measures of early childhood experiences and the unpredictability schema and experience scores.
  • Examine psychosocial and physiological variables (based on theory and past literature) that may mediate or moderate the relationship between the unpredictability schema and our primary and secondary endpoints.
  • Examine associations of metabolic measures with psychosocial measures (e.g., perceived stress, anhedonia, anxiety, depression, etc.), hormonal endpoints, or future biomarker assayed at a later time point.

Endpoints:

Primary Endpoint:

  • Ad libitum Food Intake (kcal) measured from a buffet meal task.
  • Eating in the absence of hunger (kcal) from a snack food taste test.

Secondary Endpoints:

  • Self-reported scores from the following eating measures: Eating in the Absence of Hunger Scale, Body Awareness Questionnaire, Reward-Based Eating Drive Scale, U.S. Adult food Security Survey Module, and the Three-Factor Eating Questionnaire.
  • Physical activity values and trajectories from the 10-day outpatient research accelerometer assessment.
  • Resting metabolic rate and respiratory quotient values obtained from the metabolic hood.
  • Glucose values and trajectories from fasting labs, OGTT, and 10-day outpatient CGM assessment.
  • Telomere length (t/s ratio)
  • Gut Flora Composition
  • County-level Food Swamp Score (i.e., Retail Food Environment Index)

Tertiary Endpoints:

  • Ad libitum Food Intake (kcal) measured from (1) a buffet meal task and (2) the snack food taste test; Physical activity values and trajectories from the 10-day outpatient research accelerometer assessment; Resting metabolic rate and respiratory quotient values obtained from the metabolic hood; Glucose values and trajectories from fasting labs, OGTT, and 10-day outpatient CGM assessment.
  • Ad libitum Food Intake (kcal) measured from (1) a buffet meal task and (2) the snack food taste test; Physical activity values and trajectories from the 10-day outpatient research accelerometer assessment; Resting metabolic rate and respiratory quotient values obtained from the metabolic hood; Glucose values and trajectories from fasting labs, OGTT, and 10-day outpatient CGM assessment.
  • Unpredictability schema and experience scores
  • Ad libitum Food Intake (kcal) measured from (1) a buffet meal task and (2) the snack food taste test; Physical activity values and trajectories from the 10-day outpatient research accelerometer assessment; Resting metabolic rate and respiratory quotient values obtained from the metabolic hood; Glucose values and trajectories from fasting labs, OGTT, and 10-day outpatient CGM assessment.
  • Plasma hormone, metabolite and protein concentration measured following data collection.

연구 유형

관찰

등록 (추정된)

110

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

    • Arizona
      • Phoenix, Arizona, 미국, 85014
        • NIDDK, Phoenix

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

샘플링 방법

확률 샘플

연구 인구

The study will enroll healthy, non-pregnant, women and men aged 18-60 years old who are without diabetes from the Greater Phoenix area, Arizona, United States. The study anticipates screening/enrolling 310 participants to achieve a goal of 110 participants completing the study.

설명

  • INCLUSION CRITERIA:

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

  • Stated willingness to comply with all study procedures and availability for the duration of the study.
  • 18-60 years of age.
  • Able to read and understand English proficiently (to be able to complete the multiple study questionnaires and instruments).

EXCLUSION CRITERIA:

An individual who meets any of the following criteria will be excluded from participation in this study:

  • Diabetes

    • Fasting glucose >= 126 mg/dl or HbA1c >= 6.5% or
    • Self-reported history of type 1 or type 2 diabetes.
  • Endocrine disorders, such as

    --Self-reported history of Cushing's disease, pituitary disorders, or hypo- and hyperthyroidism

  • TSH <=0.27 or >= 10 uIU/mL

  • Pulmonary disorders

    --Self-reported history of chronic obstructive pulmonary disease or other lung disease that which would limit ability to follow the protocol (investigator judgment)

  • Cardiovascular diseases,

    --Self-reported history of coronary heart disease, heart failure, arrhythmias, and peripheral artery disease that which would limit ability to follow the protocol (investigator judgment)

  • Liver disease,

    • Advanced liver disease (as determined by history, labs, exams, and patient self-report) that which would limit ability to follow the protocol (investigator judgment)
    • AST or ALT elevations > 3 times upper limit of normal
  • Gastrointestinal Surgery

    --Self-reported history of bariatric surgery

  • Renal disease

    • Self-reported history of renal replacement therapy
    • Abnormal kidney function (defined as eGFR <60 mL/min/1.73m^2) determined at screening (eGFR values are computed using the 2021 CKD-epi equation)
  • Central nervous system disease:

    --Including self-reported history of previous history of cerebrovascular accidents, dementia, and neurodegenerative disorders

  • Infectious disease:

    --Self-reported history of active tuberculosis, HIV, chronic coccidiomycosis or other chronic or acute infections

  • For Females: pregnancy, <=6 months postpartum, currently breastfeeding, or on birth control (i.e., ingested, injected or implanted; non-hormonal methods such as copper IUD will be allowed)

  • Measured weight: greater than or equal to 450 lb. (maximum weight allowed on the DXA scanning tables by the manufacturer)

  • Inability to provide informed consent.

  • Self-reported history of psychological conditions including (but not limited to), active psychosis, schizophrenia, eating disorders, or forms of mental incapacity that would be incompatible with safe and successful participation in this study.

  • Current use of medications/dietary supplements/alternative therapies known to alter energy metabolism.

  • Inability to consume provided food during ad libitum food intake or snack food test based on a food allergy or intolerances or diet restrictions.

  • Any disorder not covered by any other exclusion criteria which, in the investigator's and/or team's opinion jeopardizes the safety of the participant or others or would interfere with adherence to the protocol.

  • Alcohol Abuse as defined by >= 8-point score on the Alcohol Use Disorders Identification Test (AUDIT) questionnaire will be an exclusion criterion.

  • Current use of tobacco products that exceed "Very Low Dependence" on the Fagerstrom Test for Nicotine Dependence Tool (score greater than 2) will be an exclusion criterion.

Non-English-speaking subjects as a population will be excluded from participation in this protocol. Primary and secondary hypotheses of the protocol relate to a battery of psychological questionnaires and performances tests which are administered throughout the study. There are currently no validated, translated forms of these questionnaires and tests available; therefore, we will restrict enrollment to English speaking subjects only.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: COHORT
  • 시간 관점: PROSPECTIVE

코호트 및 개입

그룹/코호트
Healthy Volunteer

adults, age 18-60 years

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
To determine whether an association exists between unpredictability schema measures and ad libitum food intake.
기간: Day 10

Ad libitum Food Intake (kcal) measured from a buffet meal task.

Day 10
To determine whether an association exists between the unpredictability schema and experience scores and eating in the absence of hunger
기간: Day 10

Eating in the absence of hunger (kcal) from a snack food taste test.

Day 10

2차 결과 측정

결과 측정
측정값 설명
기간
To determine whether an association exists between measures of the unpredictability schema and experience scores and physical activity.
기간: Day 10

Physical activity values and trajectories from the 10-day outpatient research accelerometer assessment

Day 10
To determine whether an association exists between measures of the unpredictability schema and experience scores and resting metabolic rate and RQ.
기간: Day 10

Resting metabolic rate and respiratory quotient values obtained from the metabolic hood.

Day 10
To determine whether an association exists between measures of the unpredictability schema and experience scores and glucose values (CGM and OGTT)
기간: Day 10

Glucose values and trajectories from fasting labs, OGTT, and 10-day outpatient CGM assessment, including mean, standard deviation, area-under-the-curve, and estimated a1c

Day 10
To determine whether an association exists between measures of the unpredictability schema and experience scores and telomere length
기간: Day 10

Telomere length (t/s ratio)

Day 10
To determine whether an association exists between measures of the unpredictability schema and experience scores and with gut microbiota composition.
기간: Day 10

Gut Flora Composition

Day 10
To determine whether an association exists between measures of the unpredictability schema and experience scores with county-level food swamp statistics (i.e., Retail Food Environment Index).
기간: Day 10

County-level Food Swamp Score (i.e., Retail Food Environment Index)

Day 10
To determine whether an association exists between the unpredictability schema and experience scores and self-reported appetitive eating traits and behavior
기간: Day 10

Self-reported scores from the following eating measures: Eating in the Absence of Hunger Scale, Body Awareness Questionnaire, Reward-Based Eating Drive Scale, U.S. Adult food Security Survey Module, and the Three-Factor Eating Questionnaire.

Day 10

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Tomas Cabeza De Baca, Ph.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 11월 8일

기본 완료 (추정된)

2027년 1월 30일

연구 완료 (추정된)

2027년 1월 30일

연구 등록 날짜

최초 제출

2024년 11월 13일

QC 기준을 충족하는 최초 제출

2024년 11월 14일

처음 게시됨 (실제)

2024년 11월 15일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 3일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 2일

마지막으로 확인됨

2026년 9월 17일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다